MAPT and Alzheimer disease: Besides, considering the close association between tau and neurodegeneration in Alzheimer’s disease [12], heterogeneity in cognitive trajectories and clinical progressions across tau stages also indicates that a single dichotomous classification of the neurodegeneration dimension is an oversimplification.